Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity-Reference-Cited by-同舟云学术

Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity

Published:2011-12-29 Issue:1 Volume:64 Page:67-76
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Foltz Violaine,Gandjbakhch Frédérique,Etchepare Fabien,Rosenberg Carole,Tanguy Marie Laure,Rozenberg Sylvie,Bourgeois Pierre,Fautrel Bruno

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference48 articles.

1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis;Karonitsch;Ann Rheum Dis,2008

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs;Smolen;Ann Rheum Dis,2010

3. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

4. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score;Van der Heijde;Ann Rheum Dis,1990

5. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results;Van der Heijde;Ann Rheum Dis,2005

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective chapter: Musculoskeletal ultrasound in inflammatory joint diseases;Ultrasound - The Next Step in Clinical Evaluation [Working Title];2024-08-30

2. Correlation of US-7 and US-9 Scores with Disease Activity Score using 28 Joint Counts (DAS28) in Patients with Rheumatoid Arthritis;IRAN J MED SCI;2024

3. A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: a STARTER study post-hoc analysis;Rheumatology;2024-02-13

4. Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis;Mayo Clinic Proceedings;2024-01

5. Comparison of Hand-Wrist Findings of Rheumatoid Arthritis Patients According to the Use of Synthetic and Biological Disease-Modifying Antirheumatic Drugs (DMARDs): A Clinical, Radiographic, and Ultrasonographic Study;Cureus;2023-10-11